UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $73 to $80.
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $73 to $80.